Abstract
Fertility issues should be addressed to all patients in reproductive age before cancer treatment. In men, cryopreservation of sperm should be offered to all cancer patients in reproductive age regardless of the risk of gonadal failure. In women, the recommendation of fertility preservation should be individualized based on multiple factors such as the urgency of treatment, the age of the patient, the marital status, the regimen and dosage of cancer treatment.
Original language | English |
---|---|
Pages (from-to) | 465-468 |
Number of pages | 4 |
Journal | Journal of Assisted Reproduction and Genetics |
Volume | 29 |
Issue number | 6 |
DOIs | |
Publication status | Published - Jun 2012 |
Keywords
- Breast cancer
- Cancer
- Cancer survival
- Chemotherapy
- Fertility
- Fertility preservation
- GnRH agonist
- Gonadal failure
- Leukemia
- Lymphoma
- Oocyte cryopreservation
- Ovarian tissue cryopreservation
- Primary ovarian insufficiency
ASJC Scopus subject areas
- Reproductive Medicine
- Genetics
- Obstetrics and Gynaecology
- Developmental Biology
- Genetics(clinical)